Showing results (51-60 of 99) with videos related to

Sort By:
Pageof 10
Fetal Diagnosis and Therapy|September 27, 2021
Taiwanese Clinical Experience with Noninvasive Prenatal Testing for DiGeorge SyndromeTzu-Yi Lin, T'sang-T'ang Hsieh, Po-Jen Cheng, et al.
Molecular Pharmaceutics|May 24, 2019
Avapritinib: A Selective Inhibitor of KIT and PDGFRα that Reverses ABCB1 and ABCG2-Mediated Multidrug Resistance in Cancer Cell LinesChung-Pu Wu, Sabrina Lusvarghi, Jyun-Cheng Wang, et al.
Taiwanese Journal of Obstetrics & Gynecology|July 15, 2014
A retrospective study on the course and outcome of fetal ventriculomegalyTsung-Hong Chiu, Ghazali Haliza, Ying-Hsuan Lin, et al.
Journal of Neuroinflammation|November 28, 2017
Genetic deletion or pharmacological inhibition of soluble epoxide hydrolase reduces brain damage and attenuates neuroinflammation after intracerebral hemorrhageChun-Hu Wu, Song-Kun Shyue, Tai-Ho Hung, et al.
American Journal of Cancer Research|February 18, 2020
MY-5445, a phosphodiesterase type 5 inhibitor, resensitizes ABCG2-overexpressing multidrug-resistant cancer cells to cytotoxic anticancer drugsChung-Pu Wu, Sabrina Lusvarghi, Pin-Jung Tseng, et al.
Journal of Rehabilitation Medicine|February 7, 2009
Prevalence and risk factors for upper extremity entrapment neuropathies in polio survivorsHung-Chih Tsai, Tai-Ho Hung, Chien-Cheng Chen, et al.
Journal of Biomedical Science|July 17, 2019
Activation of TrkB/Akt signaling by a TrkB receptor agonist improves long-term histological and functional outcomes in experimental intracerebral hemorrhageChun-Hu Wu, Chien-Cheng Chen, Tai-Ho Hung, et al.
Journal of Neuroinflammation|March 13, 2016
Treatment with TO901317, a synthetic liver X receptor agonist, reduces brain damage and attenuates neuroinflammation in experimental intracerebral hemorrhageChun-Hu Wu, Chien-Cheng Chen, Chai-You Lai, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|October 21, 2025
The fourth-generation EGFR tyrosine kinase inhibitor BLU-945 resensitizes ABCG2-overexpressing multidrug-resistant non-small cell lung cancer cells to cytotoxic anticancer drugsYen-Ching Li, Bing-Huan Lin, Megumi Murakami, et al.
The Journal of Pharmacy and Pharmacology|March 16, 2026
Befotertinib restored chemosensitivity to multidrug-resistant cancer cells by inhibiting the drug efflux activity of ABCB1Yen-Ching Li, Megumi Murakami, Yang-Hui Huang, et al.
Pageof 10